SCORTECHINI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 659
EU - Europa 364
AS - Asia 78
OC - Oceania 2
AF - Africa 1
Totale 1.104
Nazione #
US - Stati Uniti d'America 658
IT - Italia 111
UA - Ucraina 50
SE - Svezia 49
IE - Irlanda 47
TR - Turchia 27
DE - Germania 25
BE - Belgio 22
DK - Danimarca 19
FI - Finlandia 13
FR - Francia 13
GB - Regno Unito 13
SG - Singapore 13
CN - Cina 12
KR - Corea 12
IN - India 8
JP - Giappone 5
AU - Australia 2
CA - Canada 1
IR - Iran 1
NL - Olanda 1
NO - Norvegia 1
ZA - Sudafrica 1
Totale 1.104
Città #
Chandler 130
Fairfield 54
Jacksonville 52
Ashburn 51
Dublin 47
New York 38
Centro 34
Wilmington 31
Des Moines 28
Cambridge 24
Seattle 24
Woodbridge 24
Houston 23
Brussels 22
Lawrence 16
Princeton 16
Turin 16
Ann Arbor 15
Boardman 15
San Mateo 12
Beijing 11
Redmond 9
Civitanova Marche 7
San Diego 7
Jesi 5
Washington 5
Milan 4
Mumbai 4
Porto 4
Pune 4
London 3
Rome 3
Ancona 2
Fano 2
Gwangju 2
Helsinki 2
Kagoya 2
Malo 2
Norwalk 2
Palermo 2
Parma 2
Sydney 2
Bubbiano 1
Chiswick 1
Group 1
Hounslow 1
Johannesburg 1
Kilburn 1
Lequile 1
Marche 1
Miami 1
Modena 1
Montecassiano 1
Montreal 1
Nanning 1
Oslo 1
Paris 1
Philadelphia 1
Porto Recanati 1
Portsmouth 1
Prescot 1
Reggio Calabria 1
Sabz 1
Sant'angelo In Vado 1
Southwark 1
Termoli 1
Totale 782
Nome #
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 116
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 103
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 87
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 81
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 76
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 76
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study 74
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 72
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 71
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 67
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 66
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 65
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 63
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT. 49
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 41
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 33
Totale 1.140
Categoria #
all - tutte 4.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.910


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 2 0 0 1 0
2019/202077 4 0 10 0 14 0 13 3 11 1 8 13
2020/2021200 12 18 17 0 20 7 39 17 28 12 20 10
2021/2022175 13 31 8 8 5 8 12 14 10 18 17 31
2022/2023333 28 44 23 27 26 60 0 10 65 1 35 14
2023/2024173 32 16 10 17 27 64 5 2 0 0 0 0
Totale 1.140